Skip to content
Riskpilot
← Back to search
Sign in
Get full access
BioInvent International Aktiebolag
AB
Active
Org 5565377263
Sölvegatan 41, 223 62
Lund
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 1997
112 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
BioInvent International Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
94M
187M
281M
375M
147M
2020
19M
2021
326M
2022
71M
2023
45M
2024
EBITDA
SEK millions
0M
-15M
-29M
-44M
-59M
-76M
2020
-279M
2021
-51M
2022
-370M
2023
-471M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
147 372
19 384
326 126
71 461
44 686
Staff expenses
—
—
—
—
—
EBITDA
−75 722
−278 550
−51 398
−370 402
−471 485
Depreciation & amort.
—
—
—
—
—
EBIT
−75 722
−278 550
−51 398
−370 402
−471 485
Net financials
−1 677
220
8 924
40 476
42 352
Profit before tax
−76 250
−278 130
−42 330
−329 926
−429 133
Tax
−0
−0
−0
−204
−135
Net profit
−76 250
−278 130
−42 330
−330 130
−429 268
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
792 031
1 420 253
1 686 733
1 378 592
973 585
Equity
743 845
1 367 647
1 606 955
1 310 734
886 929
Long-term debt
0
0
0
0
0
Short-term debt
48 186
52 606
79 778
67 858
86 656
Total debt
48 186
52 606
79 778
67 858
86 656
Financial ratios
5-year trend
EBITDA margin
-1055.1%
This company
15.8%
Market median
-6778% vs market
2020
2024
Equity ratio
91.1%
This company
38.2%
Market median
+138% vs market
2020
2024
Return on equity
-48.4%
This company
18.4%
Market median
-363% vs market
2020
2024
Net profit margin
-960.6%
This company
8.1%
Market median
-11959% vs market
2020
2024
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
2020
2024
Debt / equity
0.10×
This company
0.62×
Market median
+84% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on BioInvent International Aktiebolag
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
